Nivolumab demonstrated superior efficacy in LA-HNSCC, abenacianine received fast track designation for lung cancer surgery, the combination of amivantamab and lazertinib showed OS improvement in NSCLC, and sunvozertinib has been granted priority review status for NSCLC. READ MORE: https://hubs.li/Q0338gq80 | Targeted Oncology | Facebook
1:35
Nivolumab demonstrated superior efficacy in LA-HNSCC, abenaciani…
71 views3 weeks ago
FacebookTargeted Oncology
28 reactions · 11 shares | Important updates on locally advanced head...
3:11
28 reactions · 11 shares | Important updates on locally advanced head...
2K views2 weeks ago
FacebookESMO - European Society for Medical Oncology
Historic Perspective on Systemic Therapy for Advanced HNSCC | OncLive
Historic Perspective on Systemic Therapy for Advanced HNSCC | O…
Dec 22, 2016
onclive.com
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSCC at AACR 2025
1:05
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSC…
10 months ago
oncologytube.com
Genetic Landscape of HNSCC
Genetic Landscape of HNSCC
Aug 10, 2017
onclive.com
UbiVac Announces Preliminary Immunological Data from 1st-In-Human Trial of DPV-001 Immunotherapy Trio for Advanced HNSCC
UbiVac Announces Preliminary Immunological Data from 1st-In-H…
Apr 8, 2022
einnews.com
Petosemtamab (MCLA-158) With Pembrolizumab as First-Line (1L) Treatment of PD-L1 Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 2 Trial | OncLive
Petosemtamab (MCLA-158) With Pembrolizumab as First-Line (1L) …
8 months ago
onclive.com
Dr. Bourhis on the OS Benefit of Xevinapant Plus Chemoradiothera…
Oct 28, 2022
onclive.com
2:09
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus P…
Aug 8, 2024
onclive.com
Dr Mehra on the Design of the OrigAMI-5 Trial of Amivantamab-B…
1 week ago
onclive.com
33:50
Immunotherapy for recurrent or metastatic HNSCC: What are the p…
824 viewsJan 31, 2022
YouTubeTouch Medical Media
30:54
Staying ahead of the curve in HNSCC care: Refining the role of i…
30 views4 months ago
YouTubeTouch Medical Media
Immunotherapy in HNSCC
2.1K viewsJun 20, 2016
YouTubeOncLive
0:49
Ficerafusp alfa: a potential treatment for HNSCC and other E…
11 months ago
linkedin.com
59:45
Mount Sinai Dept. of Otolaryngology Modeling Dormancy and Metastasi…
375 viewsDec 28, 2016
YouTubeMount Sinai Health System
4:52
Immunotherapy for Virally Induced vs High–Mutation Burden HNSCC
283 viewsFeb 7, 2017
YouTubeOncLive
5:14
Immunotherapy for Recurrent HNSCC
321 viewsFeb 20, 2017
YouTubeOncLive
1:03
Dr Sun on Tisotumab Vedotin in Recurrent or Metastatic HNSCC
136 viewsJun 26, 2024
YouTubeOncLive
9:40
Emerging Agents to Treat HNSCC
169 viewsJul 17, 2017
YouTubeOncLive
4:39:32
Clinical Trial Endpoint for Locally Advanced Head and Neck Squamo…
2.7K viewsNov 9, 2021
YouTubeU.S. Food and Drug Administration
0:37
Tune in to watch Lillian L. Siu, MD, FRCPC, discuss the background f…
39 views2 months ago
FacebookOncLive
3:51
Checkpoint Inhibitors in HNSCC
448 viewsJul 6, 2017
YouTubeOncLive
3:37
基于配体受体组的HNSCC分子分型与预后关联
5 views11 months ago
bilibili影像组学科研学习
4:29
Prognostic Factors for HNSCC
804 viewsNov 14, 2016
YouTubeOncLive
11:47
Pembrolizumab in HNSCC
647 viewsJul 10, 2017
YouTubeOncLive
5:22
New Therapies for HNSCC
170 viewsAug 31, 2017
YouTubeOncLive
9:15
Historic Perspective on Systemic Therapy for Advanced HNSCC
170 viewsDec 22, 2016
YouTubeOncLive
Therapy Testing in a Spheroid-based 3D Cell Culture Model for H…
Oct 29, 2024
nih.gov
7:28
Surgery and Radiotherapy for HNSCC
138 viewsDec 16, 2016
YouTubeOncLive
See more videos
Static thumbnail place holder